You have 9 free searches left this month | for more free features.

Tauopathies

Showing 1 - 25 of 69

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tauopathies Trial in Philadelphia (Amyloid PET scan, Brain MRI Scan, Neurologic exam)

Recruiting
  • Tauopathies
  • Amyloid PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 14, 2023

Progressive Supranuclear Palsy, Corticobasal Syndrome Trial in San Francisco (Fasudil)

Active, not recruiting
  • Progressive Supranuclear Palsy
  • Corticobasal Syndrome
  • San Francisco, California
    University of California Weill Institute for Neurosciences
May 31, 2022

Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

Active, not recruiting
  • Tauopathies
  • 11C-HY-2-15 PET
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2023

Human CNS Tau Kinetics in Tauopathies

Completed
  • Progressive Supranuclear Palsy (PSP)
  • +2 more
  • 13C6 Leucine
  • Saint Louis, Missouri
    Washington University in St. Louis School of Medicine
Apr 12, 2022

Alzheimer, Dementia, Brain Diseases Trial in Farmington, Atlanta (Tele-Savvy, Caregiving During Crisis (Educational Program))

Active, not recruiting
  • Alzheimer Disease
  • +8 more
  • Tele-Savvy
  • Caregiving During Crisis (Educational Program)
  • Farmington, Connecticut
  • +1 more
Dec 9, 2022

Alzheimer, Mild Cognitive Impairment, Dementia Trial in Montpellier, Nîmes, Perpignan (Measurement of amyloid and pTau blood

Recruiting
  • Alzheimer Disease
  • +3 more
  • Measurement of amyloid and pTau blood biomarkers
  • Montpellier, Occitanie, France
  • +2 more
Jun 29, 2022

Healthy Volunteers, Tauopathies, Alzheimer Trial in Long Beach (APNmAb005, Placebo)

Recruiting
  • Healthy Volunteers
  • +2 more
  • Long Beach, California
    Collaborative Neuroscience Research, LLC., 2600 Redondo Ave.
Jun 1, 2022

Mild Cognitive Impairment (MCI), Alzheimer, Dementia Trial (XPro1595, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment (MCI)
  • +8 more
  • (no location specified)
Aug 16, 2022

Alzheimer, Dementia, Brain Diseases Trial in Macquarie Park (XPro1595, Placebo)

Recruiting
  • Alzheimer Disease
  • +8 more
  • Macquarie Park, New South Wales, Australia
    INmune Bio Investigational Site
Aug 15, 2022

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

Recruiting
  • Alzheimer's Disease
  • +8 more
  • L-Leucine 13C6
  • Saint Louis, Missouri
    Washington University in Saint Louis
Apr 12, 2022

Alzheimer, Dementia, Brain Diseases Trial in Lexington (Harmony at HOME (H@H))

Recruiting
  • Alzheimer Disease
  • +8 more
  • Harmony at HOME (H@H)
  • Lexington, Kentucky
    University of Kentucky
Mar 21, 2022

Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan Trial (18F-PMPBB3 (APN-1607) PET imaging)

Recruiting
  • Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
  • 18F-PMPBB3 (APN-1607) PET imaging
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 24, 2022

Alzheimer's Disease, Cognitive Impairment, Tauopathies Trial in Worldwide (ACI-35.030, Placebo, JACI-35.054)

Active, not recruiting
  • Alzheimer's Disease
  • +6 more
  • ACI-35.030
  • +2 more
  • Helsinki, Finland
  • +8 more
Jun 24, 2022

Parkinsonism Trial in Taoyuan City (F-18)

Completed
  • Parkinsonism
  • Taoyuan City, Guishan Dist, Taiwan
    Chang Gung Memorial Hospital,Linkou
Jan 25, 2021

Laryngopharyngeal Function in MSA, PD, and 4repeat Tauopathies

Recruiting
  • Multiple System Atrophy
  • +2 more
    • Innsbruck, Tirol, Austria
    • +9 more
    Sep 21, 2021

    Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia Trial in Taoyuan (PMPBB3, AV45)

    Recruiting
    • Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia
    • Taoyuan, Guishan, Taiwan
      Department of Neurology, Chang-Gung memorial Hospital
    Oct 3, 2021

    Healthy Volunteer, Alzheimer, Frontotemporal Dementia Trial in Seoul ([18F]PI-2620)

    Completed
    • Healthy Volunteer
    • +3 more
    • Seoul, Korea, Republic of
      Asan Medical Center
    Dec 11, 2020

    Primary Four Repeat Tauopathies (4RT), Corticobasal Syndrome (CBS), Progressive Supranuclear Palsy (PSP) Trial in Birmingham,

    Completed
    • Primary Four Repeat Tauopathies (4RT)
    • +3 more
    • TPI 287 2 mg/m2
    • +3 more
    • Birmingham, Alabama
    • +1 more
    Apr 13, 2020

    Mild Cognitive Impairment, Alzheimer, Alzheimer Dementia Trial in Auckland (N-831(Traneurocin) 10 mg QD, NA-831 (Traneurocin) 20

    Completed
    • Mild Cognitive Impairment
    • +9 more
    • N-831(Traneurocin) 10 mg QD
    • +3 more
    • Auckland, New Zealand
    • +1 more
    Jun 26, 2020

    4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

    Recruiting
    • Corticobasal Degeneration (CBD)
    • +5 more
    • Observational Study
    • San Diego, California
    • +7 more
    May 18, 2021

    Primary Tauopathies, Corticobasal Degeneration Syndrome, Frontotemporal Lobar Degeneration With Tau Inclusions Trial in San

    Terminated
    • Primary Tauopathies
    • +5 more
    • San Francisco, California
      UCSF Memory and Aging Center
    Dec 17, 2019

    Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Tauopathies Trial in New York (18F-AV-1451)

    Completed
    • Frontotemporal Lobar Degeneration (FTLD)
    • +2 more
    • New York, New York
      Morton A. Kreitchman PET Center
    Nov 18, 2019

    Primary Tauopathy Corticobasal Degeneration Syndrome (CBD) Trial (ABBV-8E12)

    No longer available
    • Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)
    • (no location specified)
    Aug 16, 2019

    Alzheimer, Dementia, Brain Diseases Trial in Worldwide (Donanemab, Placebo)

    Not yet recruiting
    • Alzheimer Disease
    • +8 more
    • Brussels, Bruxelles-Capitale, Région De, Belgium
    • +147 more
    Aug 18, 2022

    Predicted Tauopathies, Including, Progressive Supranuclear Palsy, Frontotemporal Dementia With Parkinsonism Linked to Chromosome

    Completed
    • Predicted Tauopathies, Including
    • +4 more
    • davunetide (AL-108, NAP)
    • Placebo nasal spray
    • San Francisco, California
      University of California, San Francisco (UCSF)
    Apr 3, 2019